secwatch.observer — SEC 8-K summary
======================================

Issuer:     SANUWAVE Health, Inc. (SNWV)
CIK:        0001417663
Form:       8-K
Filed at:   2024-01-10T23:59:59+00:00
Accession:  0001140361-24-001728
Event type: earnings
Sentiment:  positive
Materiality: 0.70
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

SANUWAVE Q4 preliminary revenue $6.6-6.8M (record), FY 2023 $20.0-20.2M (record)
--------------------------------------------------------------------------------

- Q4 2023 preliminary revenue $6.6-6.8M, up 20-24% YoY and >30% vs Q3 2023; new quarterly record.
- FY 2023 preliminary revenue $20.0-20.2M, up 19-20% YoY; record annual revenue.
- UltraMist product line drove growth: Q4 UltraMist revenue up >30% sequentially, ~95% of total revenue.
- Full Q4 and annual results expected to be released in late March 2024 with future guidance.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1417663/000114036124001728/0001140361-24-001728-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1417663/000114036124001728/ef20018511_8k.htm
  HTML page:      https://secwatch.observer/filing/0001140361-24-001728

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer